News Category: Regulatory news
International regulators from around the world, including the HPRA, have come together to publish two statements about the importance, safety and effectiveness of vaccines. Developed by the International Coalition of Medicines Regulatory Authorities (ICMRA) for members of the public and healthcare professionals, these statements provide assurance that the global regulatory processes for the authorisation and safety monitoring of vaccines are robust, independent and focus firmly on public health.
The development of the joint statements follows a series of discussions among ICMRA members on new ways to collaborate and enhance confidence in vaccine safety and effectiveness. The importance of this collaboration is especially evident in the context of the COVID-19 pandemic and the huge ongoing efforts to develop a vaccine to combat the virus and protect global public health.
Visit the ICMRA website for further information:
The HPRA is a member of ICMRA, which acts as a forum to support international cooperation among medicines regulatory authorities. Further details on the role and strategic initiatives of ICMRA can be found on www.icmra.info.